{"disease":{"id":"recurrent-advanced-stage-endometrial-cancer-patients","name":"recurrent advanced stage endometrial cancer patients"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04885413","title":"An Open-label, Single Arm, Phase II Trial of Niraparib in Combination With Anti-PD1（Programmed Cell Death Protein 1） Antibody in Recurrent/ Advanced Stage Endometrial Cancer Patients","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":37,"lead_sponsor_name":"Sun Yat-sen University","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}